These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38148378)

  • 41. Ovicidal effect of the methanolic extract of ginger (Zingiber officinale) on Fasciola hepatica eggs: an in vitro study.
    Moazeni M; Khademolhoseini AA
    J Parasit Dis; 2016 Sep; 40(3):662-6. PubMed ID: 27605763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of putative markers of triclabendazole resistance by a genome-wide analysis of genetically recombinant Fasciola hepatica.
    Hodgkinson J; Cwiklinski K; Beesley NJ; Paterson S; Williams DJ
    Parasitology; 2013 Oct; 140(12):1523-33. PubMed ID: 23721579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 May; 106(6):1351-63. PubMed ID: 20336319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disruption of egg production by triclabendazole-resistant Fasciola hepatica following treatment with a commercial preparation of myrrh (Mirazid).
    Abdelaal MMO; Brennan GP; Hanna REB; Abdel-Aziz A; Fairweather I
    Acta Parasitol; 2017 Jun; 62(2):336-347. PubMed ID: 28426420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of artemisinin and Artemisia extracts on Haemonchus contortus in gerbils (Meriones unguiculatus).
    Squires JM; Ferreira JF; Lindsay DS; Zajac AM
    Vet Parasitol; 2011 Jan; 175(1-2):103-8. PubMed ID: 20943323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
    O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
    J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of closantel against adult triclabendazole-resistant Fasciola hepatica.
    Coles GC; Rhodes AC; Stafford KA
    Vet Rec; 2000 Apr; 146(17):504. PubMed ID: 10888001
    [No Abstract]   [Full Text] [Related]  

  • 49. Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2011 May; 177(3-4):305-15. PubMed ID: 21208747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Understanding triclabendazole resistance.
    Brennan GP; Fairweather I; Trudgett A; Hoey E; McCoy ; McConville M; Meaney M; Robinson M; McFerran N; Ryan L; Lanusse C; Mottier L; Alvarez L; Solana H; Virkel G; Brophy PM
    Exp Mol Pathol; 2007 Apr; 82(2):104-9. PubMed ID: 17398281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep.
    Turner K; Armour J; Richards RJ
    Vet Rec; 1984 Jan; 114(2):41-2. PubMed ID: 6719804
    [No Abstract]   [Full Text] [Related]  

  • 52. Brief report first report of the in vitro ovicidal activity of camel milk and its fractions on zoonotic-liver fluke (Fasciola gigantica) eggs.
    Awad DAB; Eldiarby AS; Abdallah M; Hamad A; Gawad SMA
    Vet Res Commun; 2023 Dec; 47(4):2293-2300. PubMed ID: 37249746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro antihelmintic effect of fifteen tropical plant extracts on excysted flukes of Fasciola hepatica.
    Alvarez-Mercado JM; Ibarra-Velarde F; Alonso-Díaz MÁ; Vera-Montenegro Y; Avila-Acevedo JG; García-Bores AM
    BMC Vet Res; 2015 Feb; 11():45. PubMed ID: 25890066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia.
    Elliott T; Muller A; Brockwell Y; Murphy N; Grillo V; Toet HM; Anderson G; Sangster N; Spithill TW
    Vet Parasitol; 2014 Feb; 200(1-2):90-6. PubMed ID: 24360656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increase of gluthatione S-transferase, carboxyl esterase and carbonyl reductase in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Solana MV; Fernandez V; Lamenza P; Ceballos L; Solana H
    Mol Biochem Parasitol; 2013 Oct; 191(2):63-5. PubMed ID: 24041589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
    Novobilský A; Averpil HB; Höglund J
    Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of combined chemotherapy against gastrointestinal nematodes and Fasciola hepatica in cattle.
    Ibarra-Velarde F; Vera-Montenegro Y; Nájera-Fuentes R; Sánchez-Albarran A
    Vet Parasitol; 2001 Aug; 99(3):199-204. PubMed ID: 11502367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.
    Meaney M; Savage J; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2013 Sep; 140(10):1287-303. PubMed ID: 23756576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands.
    Winkelhagen AJ; Mank T; de Vries PJ; Soetekouw R
    Emerg Infect Dis; 2012 Jun; 18(6):1028-9. PubMed ID: 22607719
    [No Abstract]   [Full Text] [Related]  

  • 60. Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 Jul; 107(2):337-53. PubMed ID: 20512589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.